Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis
- Nicole Abedrabbo
- , Emily Lerner
- , Eric Lam
- , Diana Kadi
- , Haben Dawit
- , Christian van der Pol
- , Jean Paul Salameh
- , Haresh Naringrekar
- , Robert Adamo
- , Mostafa Alabousi
- , Brooke Levis
- , An Tang
- , Ayman Alhasan
- , Ashwini Arvind
- , Amit Singal
- , Brian Allen
- , Krzysztof Bartnik
- , Joanna Podgórska
- , Alessandro Furlan
- , Roberto Cannella
*Corresponding author for this work
- Duke University
- University of Ottawa
- University of Toronto
- McMaster University
- Thomas Jefferson University
- Department of Medicine
- University of Montreal
- Taibah University
- University of Texas Southwestern Medical Center
- Medical University of Warsaw
- University of Pittsburgh
- University of Palermo
- Université Paris Cité
- University of Ulsan
- Nottingham University Hospitals NHS Trust
- Tianjin Third Central Hospital
- New York Presbyterian Hospital
- Sichuan University
- University of Zurich
- Seoul National University
- Dong-A University
- Fudan University
- Universidad Austral
- Yonsei University
- Sun Yat-Sen University
- Samsung Medical Center, Sungkyunkwan university
- QEII Health Sciences Centre
Research output: Contribution to journal › Journal article › peer-review
6
Link opens in a new tab
Scopus
citations